Skip to content

Aptima® KIT, BOX 1, REFRIGERATED, ACV/TV, 100T, IVDRecalls & reported problems

Hologic, Inc. · Aptima® CV/TV assay, 100 test, box 1 of 2 (2°C to 8°C box). The Aptima® CV/TV assay is an in vitro nucleic acid amplification test for the detection of RNA from microorganisms associated with vulvovaginal candidiasis and trichomoniasis. · Class 2

All models of Aptima (15)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 15420045512061), received between Feb 6, 2025 and Mar 12, 2026 — classified as 4 injuries.

The most frequently reported specific device problem is “Imprecise or Erratic Results” (4 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Imprecise or Erratic Results4

Patient problems

  • No Clinical Signs, Symptoms or Conditions4

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 12, 2026Imprecise or Erratic Results

    ON (B)(6) 2026, CUSTOMER REPORTED RUNNING PREVIOUSLY TESTED NEGATIVE SAMPLES WITH THE APTIMA CV/TV ASSAY ON THEIR PANTHER INSTRUMENT (SN (B)(6)) AND RECEIVING POSITIVE RESULTS FROM THE SAME SAMPLE TUBES. CUSTOMER DID NOT PROVIDE FURTHER INFORMATION ON THE NATURE OF THE SAMPLES, WORKLISTS, OR THE INITIAL OR RETEST RESULTS. LIKEWISE, CUSTOMER DID NOT PROVIDE INFORMATION ON RESULT REPORTING OR PATIENT TREATMENT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24581186 ↗
  • InjuryFeb 25, 2026Imprecise or Erratic Results

    ON FEBRUARY 10, 2026, CUSTOMER REPORTED THAT THEY RECEIVED DISCREPANT RESULTS ON TWO SAMPLES WHILE USING THE APTIMA CV/TV ASSAY (ML 910984) ON THEIR PANTHER INSTRUMENT WITH SERIAL NUMBER (SN) (B)(6). ON (B)(6) 2026, CUSTOMER INITIALLY TESTED THE TWO SAMPLES ON CV/TV WORKLIST (WL) 002503-20260204-95 AND RECEIVED A TRICHOMONAS VAGINALIS (TRICH) NEGATIVE RESULT ON SAMPLE ID (SID) (B)(6) AND A CANDIDA (C) GLABRATA NEGATIVE RESULT ON SID (B)(6). ON (B)(6) 2026, CUSTOMER PERFORMED REPEAT TESTS FOR THESE SAMPLES ON CVTV WL 002503-20260209-19 AND RECEIVED A TRICH POSITIVE RESULT ON SID (B)(6) AND A C. GLABRATA POSITIVE RESULT ON SID (B)(6). CUSTOMER THEN REPEATED ALL NEGATIVE SAMPLES FROM WL 002503-20260204-95 AND RECEIVED TWO MORE SAMPLES WITH DISCREPANT RESULTS. SIDS (B)(6) BOTH INITIALLY RESULTED TRICH NEGATIVE. ON (B)(6) 2026, CUSTOMER PERFORMED A REPEAT TEST AND RECEIVED A TRICH POSITIVE RESULT FOR SID (B)(6) ON CV/TV WL 002503-20260210-14 AND A TRICH POSITIVE RESULT FOR SID (B)(6) ON CV/TV WL 002503-20260210-17. CUSTOMER DECIDED THAT ALL SAMPLES FROM THE INITIAL CV/TV WL 002503-20260204-95 WILL BE RESULTED AS INDETERMINATE. CUSTOMER DID NOT PROVIDE ANY INFORMATION ON THE PATIENT OR P

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24447590 ↗
  • InjuryAug 13, 2025Imprecise or Erratic Results; Imprecise or Erratic Results

    ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC THAT THEY RECEIVED A DISCREPANT RESULT USING APTIMA CV/TV ASSAY MASTER LOT 913344 WHEN TESTING SAMPLES ON PANTHER FUSION PLUS INSTRUMENTS. ON (B)(6) 2025, TWO SAMPLES FROM THE SAME PATIENT WERE TESTED ON CV/TV WL-003679-20250711-09 ON PANTHER FUSION PLUS INSTRUMENT SERIAL NUMBER (B)(6) AND SAMPLE SID (B)(6) RESULTED CV NEGATIVE / TV POSITIVE WHILE SAMPLE SID (B)(6) RESULTED CV NEGATIVE / TV NEGATIVE. CUSTOMER REPORTED BOTH RESULTS TO THE PHYSICIAN/PATIENT. ON (B)(6) 2025, BOTH SAMPLES WERE RETESTED ON CV/TV WL-004306-20250716-08 ON PANTHER FUSION PLUS INSTRUMENT SERIAL NUMBER (B)(6). SAMPLE SID (B)(6) RESULTED CV NEGATIVE / TC POSITIVE AGAIN BUT SAMPLE SID (B)(6) RESULTED CV NEGATIVE / TV POSITIVE. ON THE SAME DAY THE CUSTOMER RETESTED SID (B)(6) ONE MORE TIME ON CV/TV WL-004304-20250716-03 ON PANTHER FUSION PLUS INSTRUMENT SERIAL NUMBER (B)(6) AND RESULTED CV NEGATIVE / TV POSITIVE AGAIN. CUSTOMER NOTED THEY WOULD AMEND THE SID (B)(6) RESULT TO CV NEGATIVE / TV POSITIVE. CUSTOMER DID NOT HAVE ANY INFORMATION RELATED TO PATIENT TREATMENT. HOLOGIC HAS NOT LEARNED OF ANY ADVERSE PATIENT OUTCOMES DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22799343 ↗
  • InjuryFeb 6, 2025Imprecise or Erratic Results; Imprecise or Erratic Results

    ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC THAT THEY RECEIVED DISCREPANT RESULTS USING APTIMA CV/TV ASSAY MASTER LOT: 907460 AND APTIMA TRICHOMONAS VAGINALIS ASSAY MASTER LOT: 904910 ON THE PANTHER INSTRUMENT. SAMPLE IDS#: (B)(6) WERE PART OF A CLUSTER OF FIVE POSITIVE TESTS, INITIALLY DETECTED AS TV POSITIVE USING THE APTIMA CV/TV ASSAY. THE CUSTOMER QUESTIONED THESE RESULTS AND RETESTED THE CLUSTER OF FIVE POSITIVE SAMPLES. UPON RETEST, SAMPLE IDS#: (B)(6) RESULTED TV NEGATIVE USING APTIMA TRICHOMONAS VAGINALIS ASSAY. HOLOGIC TECHNICAL SUPPORT (TS) MADE THREE ATTEMPTS TO CONTACT THE CUSTOMER TO DETERMINE IF THE RESULTS WERE REPORTED TO EITHER THE PHYSICIAN OR THE PATIENT BUT WAS UNABLE TO REACH THE CUSTOMER. NO PATIENT TREATMENT INFORMATION WAS PROVIDED BY THE CUSTOMER. HOLOGIC HAS NOT LEARNED OF ANY ADVERSE PATIENT OUTCOMES DUE TO THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21323284 ↗

Other Vaginitis and bacterial vaginosis nucleic acid detection system devices

All Vaginitis and bacterial vaginosis nucleic acid detection system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page